| scholarly article | Q13442814 |
| P50 | author | Paul Klenerman | Q7151812 |
| Rajesh Thakker | Q17502119 | ||
| Christian B Willberg | Q42318838 | ||
| Caroline M Gorvin | Q49877982 | ||
| Philip Anton van der Merwe | Q62032624 | ||
| P2093 | author name string | Chas Bountra | |
| Paul J Newey | |||
| Marcus Bridge | |||
| Mohammed Azharuddin | |||
| Russell S Drummond | |||
| Stephen J Cleland | |||
| P2860 | cites work | Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse | Q24315716 |
| Molecular mechanisms of prolactin and its receptor | Q27008904 | ||
| Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2 | Q27646645 | ||
| Structural Characterization of the Stem–Stem Dimerization Interface between Prolactin Receptor Chains Complexed with the Natural Hormone | Q27664687 | ||
| Two Independent Histidines, One in Human Prolactin and One in Its Receptor, Are Critical for pH-dependent Receptor Recognition and Activation | Q27664867 | ||
| The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor | Q27677200 | ||
| Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter | Q33318570 | ||
| Pseudohypoparathyroidism: from bedside to bench and back | Q33717559 | ||
| Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients | Q33864414 | ||
| Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene | Q33887784 | ||
| Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). | Q34283436 | ||
| JAKs and STATs in immunity, immunodeficiency, and cancer | Q34321767 | ||
| What can we learn from rodents about prolactin in humans? | Q34721567 | ||
| Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms | Q34798387 | ||
| Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors | Q36936457 | ||
| Impact of prolactin receptor isoforms on reproduction | Q37690968 | ||
| Clinical practice. Prolactinomas | Q37722140 | ||
| Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline | Q37836197 | ||
| Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. | Q37869684 | ||
| The relationship between serum prolactin concentration and pregnancy outcome in women with unexplained recurrent miscarriage | Q61839781 | ||
| Mutation analysis of the MEN1 gene in Israeli patients with MEN1 and familial isolated hyperprolactinemia | Q74297835 | ||
| Immune system development and function in prolactin receptor-deficient mice | Q77967254 | ||
| Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility | Q82707864 | ||
| Functional epitopes for site 1 of human prolactin | Q83176147 | ||
| Pathogenesis of pituitary tumors | Q83667492 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2012-2020 | |
| P577 | publication date | 2013-11-06 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Mutant prolactin receptor and familial hyperprolactinemia | |
| P478 | volume | 369 |
| Q37105552 | A G-protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) |
| Q49790053 | A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling. |
| Q49877345 | AP2? Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity |
| Q36898312 | Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders |
| Q93177352 | Association of prolactin receptor (PRLR) variants with prolactinomas |
| Q38847429 | Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology |
| Q47916242 | Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Gα11 Mutation |
| Q57280389 | Circulating prolactin concentrations and risk of type 2 diabetes in US women |
| Q58610804 | Clinical and Laboratory Characteristics of Hyperprolactinemia in Children and Adolescents: National Survey |
| Q34539085 | Conditional Deletion of the Prolactin Receptor Reveals Functional Subpopulations of Dopamine Neurons in the Arcuate Nucleus of the Hypothalamus |
| Q98178013 | Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice |
| Q90540463 | Genetics of Pituitary Tumours |
| Q41781358 | Gestational Diabetes Mellitus From Inactivation of Prolactin Receptor and MafB in Islet β-Cells |
| Q37624386 | Gα11 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy. |
| Q37025419 | Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2) |
| Q39024370 | Interactions between prolactin and kisspeptin to control reproduction. |
| Q37624367 | Knockin mouse with mutant Gα11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors |
| Q50084574 | Large-scale exome datasets reveal a new class of adaptor-related protein complex 2 sigma subunit (AP2σ) mutations, located at the interface with the AP2 alpha subunit, that impair calcium-sensing receptor signalling |
| Q92110199 | Mice with a Brd4 Mutation Represent a New Model of Nephrocalcinosis |
| Q60406162 | Mutant prolactin receptor—when lock and key no longer fit |
| Q52373139 | N-ethyl-N-nitrosourea-Induced Adaptor Protein 2 Sigma Subunit 1 (Ap2s1) Mutations Establish Ap2s1 Loss-of-Function Mice. |
| Q49787594 | Natural and molecular history of prolactinoma: insights from a Prlr-/- mouse model |
| Q38381546 | New insights in prolactin: pathological implications |
| Q36716025 | Pituitary Medicine From Discovery to Patient-Focused Outcomes |
| Q90724936 | Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues |
| Q33654808 | Prolactin induces apoptosis of lactotropes in female rodents |
| Q38282726 | Prolactin-induced prostate tumorigenesis |
| Q38524488 | The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications |
| Q47137743 | The prolactin receptor: Diverse and emerging roles in pathophysiology |
| Q38626657 | The role of prolactin in andrology: what is new? |
Search more.